5,005 Shares in Aflac Incorporated $AFL Acquired by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP purchased a new position in Aflac Incorporated (NYSE:AFL – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,005 shares of the financial services provider’s stock, valued at approximately $569,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Archer Investment Corp bought a new position in Aflac in the 2nd quarter valued at $26,000. Groupe la Francaise purchased a new stake in Aflac in the first quarter worth $25,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Aflac during the second quarter worth $27,000. Washington Trust Advisors Inc. bought a new stake in shares of Aflac during the second quarter worth $29,000. Finally, Markowski Investments bought a new stake in shares of Aflac during the second quarter worth $29,000. 67.44% of the stock is owned by institutional investors.

Aflac Price Performance

AFL opened at $127.44 on Monday. Aflac Incorporated has a 12-month low of $105.76 and a 12-month high of $131.18. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.30. The business’s fifty day simple moving average is $118.47 and its 200-day simple moving average is $116.66. The company has a market capitalization of $63.03 billion, a price-to-earnings ratio of 18.58, a PEG ratio of 1.78 and a beta of 0.55.

Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.43 EPS for the quarter, beating the consensus estimate of $1.80 by $0.63. The firm had revenue of $4.30 billion for the quarter, compared to analyst estimates of $4.12 billion. Aflac had a return on equity of 12.82% and a net margin of 21.24%. The business’s revenue for the quarter was down 31.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.49 earnings per share. On average, equities research analysts anticipate that Aflac Incorporated will post 7.37 earnings per share for the current fiscal year.

Aflac Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be issued a dividend of $0.64 per share. This represents a $2.56 annualized dividend and a yield of 2.0%. The ex-dividend date is Wednesday, February 17th. This is a positive change from Aflac’s previous quarterly dividend of $0.61. Aflac’s dividend payout ratio (DPR) is currently 35.57%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on AFL shares. Wells Fargo & Company boosted their target price on shares of Aflac from $116.00 to $124.00 and gave the company an “equal weight” rating in a research note on Thursday. JPMorgan Chase & Co. raised their price target on shares of Aflac from $116.00 to $119.00 and gave the stock a “neutral” rating in a research note on Thursday, October 15th. Piper Sandler lifted their price objective on shares of Aflac from $138.00 to $143.00 and gave the company an “overweight” rating in a report on Monday, November 9th. TD Cowen reissued a “hold” rating and issued a $110.00 price objective (up from $101.00) on shares of Aflac in a research report on Wednesday, July 22nd. Finally, Mizuho upped their target price on shares of Aflac from $112.00 to $117.00 and gave the stock an “underperform” rating in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $118.73.

Check Out Our Latest Research Report on AFL

Recent Aflac Headlines

These are some of the AFL headlines that stood out recently:

  • Neutral Sentiment: Wells Fargo raised its price target to $124 and JPMorgan to $121 from $119. The higher targets are modestly constructive, though they remain below the recent share price; Wells Fargo maintained an “equal weight” rating. Wells Fargo target update JPMorgan target update
  • Neutral Sentiment: Director Joseph Moskowitz sold 600 shares and major shareholder Post Holdings’ Japan entity sold 13,000 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans and were small compared with their remaining holdings.
  • Negative Sentiment: Mizuho raised its target to $117 from $112 but retained an “underperform” rating, signaling limited upside in its view. Mizuho forecast update

Insider Transactions at Aflac

In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 113,611 shares of the firm’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $118.53, for a total transaction of $13,466,311.83. Following the transaction, the insider owned 50,134,329 shares of the company’s stock, valued at approximately $5,942,422,016.37. This trade represents a 0.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 685,662 shares of company stock worth $80,001,262. 0.80% of the stock is owned by corporate insiders.

Aflac Profile

(Free Report)

Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.

See Also

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.